跳至主要内容
临床试验/CTRI/2022/03/040730
CTRI/2022/03/040730尚未招募2 期

A comparative evaluation of antiurolithiatic and litholytic activity of shwadamshtradi ghana vati and potassium citrate tablet in the management of mutrashmari (urolithiasis): a randomized controlled clinical trialâ??

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Kidney stone size up to 15 mm
  • 2. Ureteric Stone size up to 8 mm
  • 3. Urinary Bladder Stone size up to 15 mm
  • 4. Radiographic and /or USG evidence of the stone
  • 5. Patients of Ashmari with controlled Hypertension & Diabetes Mellitus.

排除标准

  • 1.Patients not willing for trial and follow up
  • 2.Chronic Renal failure.
  • 3.Gross Hydronephrosis.
  • 4.Acute abdominal pain.
  • 5.Cases which requires surgical intervention.
  • 6.Severe Hematuria.
  • 7.Kidney stone and Bladder Stone size more than 15 mm.
  • 8.Ureteric stone Size more than 8 mm
  • 9.Known cases of Malignancy, Tuberculosis.
  • 10.Known cases of HIV (Human Immunodeficiency Virus), VDRL (Venereal Disease Research Laboratory) and Hepatitis-B positive.

研究者

相似试验